|
Two new DCA research articles published
Dichloroacetate induces apoptosis in endometrial cancer cells.
link to full text
CONCLUSIONS: Dichloroacetate effectively sensitizes most endometrial cancer cell lines to apoptosis via mitochondrial, NFAT-Kv1.5, and PUMA-mediated mechanisms. Further investigation of the cancer therapeutic potential of DCA is warranted. |
DCA reports
and emails
Click here
(Updated 10 May 2008)
DCA with Caffeine has been connected to five remissions
#3, cholangiocarcinoma Click
#4, a NSCLC Click
#5 canine bladder cancer Click
DCA-caffeine protocol
Full DCA-Caffeine
Survey
Results
Click here
(updated May 8, 2008) |
Dichloroacetate (DCA) Sensitizes Both Wild-Type and Over Expressing Bcl-2 Prostate Cancer Cells In Vitro to Radiation
Link to full text
CONCLUSIONS. This is the first study to demonstrate DCA can effectively sensitize wild-type
and over expressing Bcl-2 human prostate cancer cells to radiation by modulating the expression
of key members of the Bcl-2 family. Together, these findings warrant further evaluation of the
combination of DCA and irradiation.
Updated 10 May 2008 |
|
Warning: Brain cancer patients who take DCA are at risk. click here |
Welcome to The DCA Site
 |
|
 |
This site is to help inform people of the exciting research done on DCA by scientists at the University of Alberta. In January 2007, a team of scientists at the University of Alberta published a paper in the scientific journal, Cancer Cell, describing the discovery that a simple, cheap molecule, DCA, worked to reactivate the apoptosis mechanism of cancer cells, causing rapid shrinkage of tumors in rats. Mitochondrial reactivation represents an entirely new approach to treating cancer.
The tumors shrank 70% in three weeks.
DCA is not patentable as a molecule. There is no incentive for private companies to spend the millions of dollars needed to get DCA approved as a cancer treatment by the FDA. This is where we, all of us, need to step in. We intend for TheDCAsite.com to be the meeting place, for the world, where all the important information on DCA is gathered and shared.
This site gives the results of the Michelakis research, a look at the possible side effects of DCA and the prospects of it being used by YOU. We have posted the best summaries we can reach on dosages, side effect concerns and additional measures to take to help you fight cancer. Questions are answered and a chat room is provided.
To avoid any legal issues, we must state we are not doctors and cannot give medical advice.
DCA has not been approved by the Food and Drug Administration for the treatment of cancer. It can be prescribed "off-label" by your physician.
Please note that DCA is not active against all cancers. An excellent analysis by "Willis", which is supported by the limited feedback we are getting, indicates that sarcomas, for example, are not controlled by DCA. (Note. sarcoma patients, read this). However, many cancers are definitely responding to DCA. Non small cell lung cancer patients, even in Stage 4 are showing good responses. We are seeing lymphatic, bladder and other cancers responding very well to DCA.
DCA is serious medicine. Study the material on the site. Read our dosage page.
We want to encourage everyone to use the Chat Room or ask the questions you want answered. We strongly recommend you join and register as a chat room user.
The site was first uploaded late on February 5, 2007. The chat room was added February 8, 2007.
This site can be translated to additional languages here:
| Translation via InterTran (www.tranexp.com) |
An older version of this page in: Chinese
DCA sites around the world:
Argentina, en espanol: http://www.dicloroacetato.info
Poland: http://www.apoptoza.pl
Russia http://www.dcainfo.ru/
Let us know of others please.
top
|
